Skip to main content
Medicine logoLink to Medicine
. 2025 Jul 18;104(29):e43289. doi: 10.1097/MD.0000000000043289

Eosinophilic gastroenteritis with negative endoscopic biopsy and no peripheral eosinophilia: A case report

Yukai Chen a, Keke Sun a, Linbo Chen a, Dewen Lu a, Chihong Shi a, Qi Lin a,*
PMCID: PMC12282817  PMID: 40696579

Abstract

Rationale:

Eosinophilic gastroenteritis (EoGE) is a rare inflammatory disease that can affect the entire gastrointestinal tract. Klein et al classified EoGE into 3 distinct subtypes according to the depth of eosinophilic infiltration: mucosal, muscular, and serosal.

Patient concerns:

We herein report a case of a 29-year-old woman who presented with abdominal pain, nausea, and vomiting, with no history of adverse reactions to any allergens. Laboratory test results revealed a normal count of peripheral blood eosinophils. Ultrasound and computed tomography revealed thickened intestinal walls and ascites in both the abdominal cavity and the pelvic cavity. Multiple endoscopic biopsies targeting several swelling segments of the intestinal wall revealed no increase in the number of eosinophils.

Diagnoses:

The constellation of clinical, laboratory, radiological findings, histopathological data, and the excellent response to corticosteroids led to a diagnosis of EoGE for the patient.

Interventions:

The patient was treated with corticosteroids.

Outcomes:

Symptoms improved rapidly, and the thickened intestinal walls returned to a typical level.

Lessons:

EoGE should be considered scrupulously, even if the count of eosinophils is in the normal range and the endoscopic biopsy is negative. Obtaining pathology of ascites as much as possible and taking a multisite biopsy sample, including both targeted and random biopsies, may improve the diagnostic rate.

Keywords: ascites, biopsy, diagnosis, eosinophilic gastroenteritis

1. Introduction

Eosinophilic gastroenteritis (EoGE) is a rare inflammatory disease, characterized by infiltration of eosinophils, which can affect the entire gastrointestinal (GI) tract.[1] Kajiser first described the disease in 1937, and there were only about 300 cases reported between 1937 and 2016.[2] In 1970, Klein et al classified EoGE into 3 distinct subtypes according to the depth of eosinophilic infiltration: mucosal, muscular and serosal. Because the symptoms of EoGE are similar to other GI diseases, the diagnosis of EoGE requires high sensitivity in the clinic.[3] We herein describe the case of a patient who suffered from EoGE presenting as edema and exudation of the gastrointestinal wall but with no positive biopsy. The results of ascites examination guide the diagnosis. Based on our case, systematic and effective biopsy sampling in EoGE is indispensable.

2. Case report

A 29-year-old woman presented to our unit with complaints of recurrent abdominal pain lasting for 4 months, with nausea and vomiting for the past 3 days. The patient gave no history of previous abdominal surgery, recent travel, or adverse reactions to any allergens. She had no medical problems in previous history.

On examination we found the patient to be totally well; body temperature was 37.3°C, blood pressure 133/84 mm Hg, heart rate 92 beats/min, oxygen saturation 99%. Her abdomen was tender with no abdominal tenderness.

Laboratory investigations were notable for a raised IgE concentration (346 IU/mL; normal 0–100) and a slightly elevated C-reactive protein concentration (13 mg/L; normal 0–6). Leukocyte count was elevated (10.7 × 109 per L; normal 3.5–9.5), while eosinophil count was 0.3 × 109 per L (normal 0–0.5). Total antinuclear antibodies concentration was 1:1000, while other tests for autoimmune diseases found nothing abnormal. All tumor markers were negative. Ultrasound showed thickened intestinal walls and ascites in the both abdominal cavity and pelvic cavity (Fig. 1). An abdominal computed tomography performed on February 13 revealed diffuse thickening and edema involving the gastric antrum, duodenum and partial small intestinal (Fig. 2A). Moreover, A computed tomography performed 1 week later revealed thickening and edema of the ascending colon while the process of intestinal walls mentioned above improved (Fig. 2B). A case discussion was conducted, and the eosinophilic gastroenteritis was possibly considered to be. Thus, blood and stool analyses, including specific serological examinations and cultures, exclude viral, bacterial, and parasitic infections. The patient had a gastrointestinal endoscopy which showed extensive swelling of the intestinal wall (Fig. 3). We obtained biopsies form the obviously swollen segments, as follows: 2 biopsies from gastric antrum, 1 biopsy from duodenum, 2 from terminal ileum, 3 from ascending colon and 6 from transverse colon, including several deep biopsies. Nevertheless, large biopsies of gastroduodenal and colonic mucosal had no positive indication: normal eosinophilic infiltration with <20 eosinophiles per high-power field (Fig. 4). Fortunately, we reevaluated the pathology smear of ascites found 2 months ago, which revealed significant eosinophilic infiltration (Fig. 5). Meanwhile, we ruled out associated vasculitis.

Figure 1.

Figure 1.

Ultrasound images. Ultrasound showed ascites in the both abdominal cavity and pelvic cavity.

Figure 2.

Figure 2.

Abdominal computed tomography scan images: (A) demonstrated diffuse thickening and edema involving the gastric antrum, duodenum and partial small intestinal; (B) demonstrated thickening and edema of the ascending colon.

Figure 3.

Figure 3.

Endoscopic appearance. Colonoscopy results showed extensive swelling of the intestinal wall.

Figure 4.

Figure 4.

Histological examination. Biopsies results showed eosinophilic infiltration <20 eosinophiles per high-power field. Hematoxylin and eosin stain.

Figure 5.

Figure 5.

The pathology smear of ascites showed significant eosinophilic infiltration. Hematoxylin and eosin stain.

The patient received intravenous hormonal therapy at first. Subsequently, oral maintenance therapy was initiated (Table 1). The patient’s condition stabilized and her symptoms improved rapidly; the thickened intestinal walls returned to a typical level. At the first outpatient follow-up 1 week later, the patient no long had any abdominal pain or nausea. As the patient said, she felt completely recovered and had understood such disease through this successful treatment.

Table 1.

The dose, type and duration of corticosteroid therapy.

Date (2024) Medicine Dosage (mg) Usage
February 24 to February 26 Methylprednisolone sodium succinate 40 ivgtt
February 27 to March 4 Prednisone tablets 30 po
March 5 to March 11 Prednisone tablets 25 po
March 12 to March 18 Prednisone tablets 20 po
March 19 to March 25 Prednisone tablets 15 po
March 26 to April 1 Prednisone tablets 10 po
April 2 to April 8 Prednisone tablets 5 po

3. Discussion

Eosinophilic gastrointestinal disorders are a spectrum of rare and heterogeneous diseases characterized by dense infiltration of eosinophils into different layers of the GI tract in the absence of secondary causes of eosinophilia.[4,5] The etiology and pathogenesis of EoGE remain obscure. Research showed that bacterial infections, hygiene status and genetic and environmental may all contribute to the etiology of EoGE.[68] Thus, a history of atopy has been reported in half of the patients with EoGE.[9] Though EoGE is accepted as a Th2-mediated allergic reaction, the pathogenesis of EoGE remains complicated, as many factors can lead to eosinophil infiltration.[10]

Although EoGE is an uncommon disease, there are increasingly incidence and prevalence. The recent prevalence in western countries is from 5 to 8 per 1,00,000.[11] EoGE can occur at any age from childhood to adulthood, in which most are diagnosed between the third and fifth decades (with a predominance in females) and is more common in the female patients.[12]

The clinical presentations of EoGE are nontypical and differ depending on the location and depth of infiltration of eosinophils. In all 3 Klein classifications, the mucosal subtype is predominant. Patients usually present with general abdominal pain, nausea, vomiting, weight loss diarrhea and even gastrointestinal bleeding.[13] The muscular subtype results in bowel wall thickening and impaired intestinal motility, which may lead to symptoms of intestinal obstruction.[12] The serosal subtype is in only 10% reported cases, presenting with eosinophilic abdominal ascites.[14] In addition, this subtype has a better response to steroid therapy, which is the most widely prescribed treatment.[12,15] These 3 subtypes can also exist together.

In 1990, Talley et al[9] proposed the following 3 diagnostic criteria: presence of gastrointestinal symptoms; histopathological findings of eosinophilic infiltration or characteristic radiological findings with peripheral eosinophilia; and no evidence of parasitic or extraintestinal disease. To date, however, no consensus has been reached for EoGE diagnosis. There are approximately 20% patients of EoGE having no elevated level of peripheral blood.[10,16,17] The most common abnormal endoscopic findings are not specific for EoGE, such as erosion, edema or erythema, and many may appear normal.[1820] Diagnosing EoGE therefore strongly relies on performing biopsies. Eosinophil infiltration can present in the stomach, intestine and colon of normal individuals, consequently, EoGE patients can exhibit the normal presence of eosinophils.[2123] Both peripheral eosinophilia and biopsy play key roles in diagnosis of EoGE. In clinical practice, insufficient biopsy sampling might produce false-negative results and missed diagnosis. Many researches have highlighted the importance of obtaining multiple biopsy samples from multiple anatomic locations, including targeted biopsies and random biopsies.[21,2428] The optimal number and location of biopsies needed to establish the diagnosis remain uncertain. Some authors suggested that at least 5 to 6 biopsies were warranted per site.[12,29,30] A retrospective US study of 509 patients showed the number of biopsy fragments ranged from 4 to 7.[31] What’s more, a study demonstrated that at least 8 gastric biopsies and 4 duodenal biopsies was required to diagnose.[20] In addition, performing at least 2 biopsies for each of the terminal ileum, ascending colon, transverse colon, descending colon, sigmoid and rectum is advised.[32,33] Even though, the positive rate of biopsy for EoGE might be low.[31,34] Laparoscopic full-thickness biopsy can be helpful in establishing the diagnosis.[23,35,36]

We present a case of a female patient with recurrent abdominal pain accompanied by nonspecific symptoms of nausea and vomiting, with obviously thickening of the gastrointestinal tract, though, without peripheral eosinophilia and positive biopsies. In our case, we gain insufficient biopsy samples by just performing biopsies in the most severe lesion. We assume that the congestion and edema might increase the difficult in obtaining positive biopsy, and multiple biopsy samples from other random or normal segments could be helpful. In all, combining the constellation of the clinical, laboratory, radiological findings, histopathological data, and the excellent response to corticosteroids, we confirm the diagnosis.

4. Conclusion

EoGE is a relatively rare chronic inflammatory disease with the nonspecific symptoms, and widely adopted diagnostic criteria is necessarily needed. According to the case, EoGE should be considered scrupulously even if the count of eosinophils is in the normal range and the endoscopic biopsy is negative. There still calls for further study to have a better understanding of the EoGE.

Author contributions

Conceptualization: Qi Lin.

Investigation: Linbo Chen, Chihong Shi.

Project administration: Qi Lin.

Resources: Qi Lin.

Supervision: Keke Sun, Dewen Lu.

Writing – original draft: Yukai Chen.

Writing – review & editing: Keke Sun.

Abbreviations:

EoGE
eosinophilic gastroenteritis
GI
gastrointestinal.

This research was supported by science and technology projects of Yinzhou district (yinke2018-58).

The ethical approval is not necessary because our article is a retrospective case and it doesn’t involve any human or animal trials. Informed consent was obtained from the patient.

The authors have no conflicts of interest to disclose.

Data sharing not applicable to this article as no datasets were generated or analyzed during the current study.

How to cite this article: Chen Y, Sun K, Chen L, Lu D, Shi C, Lin Q. Eosinophilic gastroenteritis with negative endoscopic biopsy and no peripheral eosinophilia: A case report. Medicine 2025;104:29(e43289).

YC and KS contributed to this article equally.

Contributor Information

Yukai Chen, Email: 443741973@qq.com.

Keke Sun, Email: andysun4412@126.com.

Linbo Chen, Email: 443741973@qq.com.

Dewen Lu, Email: Ludw111111@163.com.

Chihong Shi, Email: 13456140878@163.com.

References

  • [1].Khan S, Orenstein SR. Eosinophilic gastroenteritis. Gastroenterol Clin North Am. 2008;37:333–48, v. [DOI] [PubMed] [Google Scholar]
  • [2].Alhmoud T, Hanson JA, Parasher G. Eosinophilic gastroenteritis: an underdiagnosed condition. Dig Dis Sci. 2016;61:2585–92. [DOI] [PubMed] [Google Scholar]
  • [3].Klein NC, Hargrove RL, Sleisenger MH, Jeffries GH. Eosinophilic gastroenteritis. Medicine (Baltim). 1970;49:299–319. [DOI] [PubMed] [Google Scholar]
  • [4].Hahn JW, Lee K, Shin JI, et al. Global incidence and prevalence of eosinophilic esophagitis, 1976–2022: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2023;21:3270–84.e77. [DOI] [PubMed] [Google Scholar]
  • [5].Dellon ES, Gonsalves N, Abonia JP, et al. International consensus recommendations for eosinophilic gastrointestinal disease nomenclature. Clin Gastroenterol Hepatol. 2022;20:2474–84.e3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [6].Zadeh-Esmaeel MM, Rezaei-Tavirani M, Ali Ahmadi N, Vafae R. Evaluation of gene expression change in eosinophilic gastroenteritis. Gastroenterol Hepatol Bed Bench. 2019;12:239–45. [PMC free article] [PubMed] [Google Scholar]
  • [7].Furuta K, Adachi K, Aimi M, et al. Case-control study of association of eosinophilic gastrointestinal disorders with Helicobacter pylori infection in Japan. J Clin Biochem Nutr. 2013;53:60–2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [8].Dellon ES, Peery AF, Shaheen NJ, et al. Inverse association of esophageal eosinophilia with Helicobacter pylori based on analysis of a US pathology database. Gastroenterology. 2011;141:1586–92. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [9].Talley NJ, Shorter RG, Phillips SF, Zinsmeister AR. Eosinophilic gastroenteritis: a clinicopathological study of patients with disease of the mucosa, muscle layer, and subserosal tissues. Gut. 1990;31:54–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [10].Li K, Ruan G, Liu S, et al. Eosinophilic gastroenteritis: Pathogenesis, diagnosis, and treatment. Chin Med J (Engl). 2023;136:899–909. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [11].Mansoor E, Saleh MA, Cooper GS. Prevalence of eosinophilic gastroenteritis and colitis in a population-based study, from 2012 to 2017. Clin Gastroenterol Hepatol. 2017;15:1733–41. [DOI] [PubMed] [Google Scholar]
  • [12].Uppal V, Kreiger P, Kutsch E. Eosinophilic gastroenteritis and colitis: a comprehensive review. Clin Rev Allergy Immunol. 2016;50:175–88. [DOI] [PubMed] [Google Scholar]
  • [13].Rothenberg ME, Hottinger SKB, Gonsalves N, et al. Impressions and aspirations from the FDA GREAT VI workshop on eosinophilic gastrointestinal disorders beyond eosinophilic esophagitis and perspectives for progress in the field. J Allergy Clin Immunol. 2022;149:844–53. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [14].Quack I, Sellin L, Buchner NJ, Theegarten D, Rump LC, Henning BF. Eosinophilic gastroenteritis in a young girl--long term remission under Montelukast. BMC Gastroenterol. 2005;5:24. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [15].Hua S, Cook D, Walker MM, Talley NJ. Pharmacological treatment of eosinophilic gastrointestinal disorders. Expert Rev Clin Pharmacol. 2016;9:1195–209. [DOI] [PubMed] [Google Scholar]
  • [16].Kinoshita Y, Furuta K, Ishimaura N, et al. Clinical characteristics of Japanese patients with eosinophilic esophagitis and eosinophilic gastroenteritis. J Gastroenterol. 2013;48:333–9. [DOI] [PubMed] [Google Scholar]
  • [17].Pineton de Chambrun G, Gonzalez F, Canva JY, et al. Natural history of eosinophilic gastroenteritis. Clin Gastroenterol Hepatol. 2011;9:950–6.e1. [DOI] [PubMed] [Google Scholar]
  • [18].Nguyen N, Kramer RE, Friedlander JA. Videocapsule endoscopy identifies small bowel lesions in patients with eosinophilic enteritis. Clin Gastroenterol Hepatol. 2018;16:e64–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [19].Sasaki Y, Abe Y, Mizumoto N, Nomura E, Ueno Y. Small bowel endoscopic features of eosinophilic gastroenteritis. Diagnostics (Basel, Switzerland). 2022;13:113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [20].Dellon ES, Gonsalves N, Rothenberg ME, et al. Determination of biopsy yield that optimally detects eosinophilic gastritis and/or duodenitis in a randomized trial of lirentelimab. Clin Gastroenterol Hepatol. 2022;20:535–45.e15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [21].Kinoshita Y, Ishihara S. Eosinophilic gastroenteritis: epidemiology, diagnosis, and treatment. Curr Opin Allergy Clin Immunol. 2020;20:311–5. [DOI] [PubMed] [Google Scholar]
  • [22].Zhang L, Duan L, Ding S, et al. Eosinophilic gastroenteritis: clinical manifestations and morphological characteristics, a retrospective study of 42 patients. Scand J Gastroenterol. 2011;46:1074–80. [DOI] [PubMed] [Google Scholar]
  • [23].Galere P, Gilbert A. Eosinophilic gastroenteritis with ascites: an enigmatic diagnosis. Lancet (London, England). 2022;400:126. [DOI] [PubMed] [Google Scholar]
  • [24].Liang M, Liwen Z, Bingfang C, Yanbo D, Jianping C. Eosinophilic gastroenteritis with multiple serous membrane effusion as the first sign: a case report and literature review. J Int Med Res. 2020;48:300060520917274. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [25].Dellon ES, Collins MH, Bonis PA, et al. substantial variability in biopsy practice patterns among gastroenterologists for suspected eosinophilic gastrointestinal disorders. Clin Gastroenterol Hepatol. 2016;14:1842–4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [26].Fujiwara Y, Tanoue K, Higashimori A, et al. ; F-Study group . Endoscopic findings of gastric lesions in patients with eosinophilic gastrointestinal disorders. Endoscopy International Open. 2020;8:E1817–25. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [27].Amruthesh TM, Kini D, Yachha SK, Rao P, Shetty SS, Kumar V. Eosinophilic gastroenteritis: Clinical characteristics and management. Indian J Gastroenterol. 2021;40:338–43. [DOI] [PubMed] [Google Scholar]
  • [28].Pesek RD, Reed CC, Collins MH, et al. ; Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR). Association between endoscopic and histologic findings in a multicenter retrospective cohort of patients with non-esophageal eosinophilic gastrointestinal disorders. Dig Dis Sci. 2020;65:2024–35. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [29].Bedell A, Taft T, Craven MR, Guadagnoli L, Hirano I, Gonsalves N. Impact on health-related quality of life in adults with eosinophilic gastritis and gastroenteritis: a qualitative assessment. Dig Dis Sci. 2018;63:1148–57. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [30].Chen PH, Anderson L, Zhang K, Weiss GA. Eosinophilic gastritis/gastroenteritis. Curr Gastroenterol Rep. 2021;23:13. [DOI] [PubMed] [Google Scholar]
  • [31].Brenner EJ, Greenberg SB, Chang NC, Corder SR, Cowherd EL, Dellon ES. Peripheral eosinophilia and hypoalbuminemia are associated with a higher biopsy diagnostic yield for eosinophilic gastroenteritis. Clinics Res Hepatol Gastroenterol. 2021;45:101746. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [32].Reggiani Bonetti L, Leoncini G, Daperno M, et al. Histopathology of non-IBD colitis practical recommendations from pathologists of IG-IBD Group. Digest Liver Dis. 2021;53:950–7. [DOI] [PubMed] [Google Scholar]
  • [33].Villanacci V, Reggiani-Bonetti L, Caprioli F, et al. Histopathology of inflammatory bowel disease - Position statement of the pathologists of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and Italian Group of Gastrointestinal Pathologists (GIPAD-SIAPEC). Digest Liver Dis. 2020;52:262–7. [DOI] [PubMed] [Google Scholar]
  • [34].Hentschel F, Jansen AF, Günther M, Pauli R, Lüth S. Eosinophil counts in mucosal biopsies of the ileum and colon: interobserver variance affects diagnostic accuracy. Pathol Res Int. 2018;2018:2638258. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [35].Ishihara S, Kinoshita Y, Schoepfer A. Eosinophilic esophagitis, eosinophilic gastroenteritis, and eosinophilic colitis: common mechanisms and differences between east and west. Inflamm Intest Dis. 2016;1:63–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [36].Sunkara T, Rawla P, Yarlagadda KS, Gaduputi V. Eosinophilic gastroenteritis: diagnosis and clinical perspectives. Clin Exp Gastroenterol. 2019;12:239–53. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Medicine are provided here courtesy of Wolters Kluwer Health

RESOURCES